Reference scaled approach for HVD [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2009-02-09 12:26 (6348 d 00:44 ago) – Posting: # 3212
Views: 18,882

Dear Helmut! Dear All!

❝ ❝ 3. Statistical analysis: How to do [...]



❝ First you have to have suitable software (SAS, WinNonlin,...) which will give you CVintra of the reference. Then follow Method C2 given in Haidar et al. to calculate to scaled BE limits [...]


❝ [...]


❝ Procedure: if you have sigma2WR [...]


Is it really that simple? :ponder:

I have read up to now from Haidar et. al.:
"[...] Furthermore,
  theta=(ln Delta)2/sigma2W0
where Delta is 1.25, the usual average BE upper limit for the untransformed test/reference ratio of geometric means, and sigmaW0=0.25. [...] A 95% upper confidence bound for (µTR)2/sigma2WR determined in a BE study must be < theta, or equivalently, a 95% upper confidence bound forTR)2-theta*sigma2WR must be <0. [...]".
(emphasis by me)

Thus I think the statistical method must calculate a confidence interval, recommended is that for the linearized SABE criterion (last in the excerpt above). This is so because we have only estimates of (µTR) and sigma2WR with a certain variability.

Dave Dubins has given this above quote in his Fartssie.xls also, but I can not find a confidence interval calculation there in.

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
369 visitors (0 registered, 369 guests [including 18 identified bots]).
Forum time: 14:10 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5